COMP <GO>
CDRE vs JNJ // ENTERPRISE SCALE & MARKET CAP
Cadre Holdings Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CDRE 5
— JNJ 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $31.10 (+3.81%) • MKT CAP: $1.33B
market-cap
$1.33B
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDRE VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDRE | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 67.90% | -25.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.00% | 25.50% | -14.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.5x | 18.5x | +2.00 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 2.97% | +1.30 | CDRE | /fcf-yield <GO> |
| Operating Margin | 11.00% | 34.70% | -23.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 7.20% | 28.50% | -21.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 7.50% | 6.00% | +1.50 | CDRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.16% | 0.00% | +1.16 | CDRE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 5.59 | -2.27 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | CDRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.0 | 62.1 | +2.93 | CDRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 23.0x | +5.10 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.33B | $662.49B | -$661.16B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDRE REV | JNJ REV | CDRE GROSS % | JNJ GROSS % | CDRE FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $610.3M | $94.19B | 42.5% | 67.9% | $56.8M | $19.70B |
| FY 2024 | $567.6M | $88.82B | 41.1% | 69.1% | $26.1M | $19.84B |
| FY 2023 | $482.5M | $85.16B | — | — | $73.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDRE // BETA —
JNJ // BETA 1.08